Related Experiment Videos
Herpes simplex virus: benefit versus risk factors in immunization.
Developments in Biological Standardization
|January 1, 1979
Summary
This review examines herpes simplex virus (HSV) vaccines, assessing their effectiveness in preventing initial infections and managing recurrent outbreaks. It discusses challenges with live attenuated or inactivated HSV vaccines compared to other herpesvirus vaccines.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Herpes simplex viruses (HSV) cause primary infections, establish latency, and lead to recurrent herpetic lesions.
- Effective vaccines are needed to prevent HSV infection and reduce disease severity.
Purpose of the Study:
- To review the efficiency of currently available HSV vaccines.
- To discuss potential problems with live attenuated or inactivated HSV vaccines.
- To compare HSV vaccines with existing vaccines for other herpes group viruses.
Main Methods:
- Literature review of existing HSV vaccine research.
- Analysis of vaccine efficacy in preventing primary infection and latency.
- Evaluation of vaccine potential in managing recurrent herpetic lesions.
- Comparative assessment with vaccines against other human herpesviruses.
Main Results:
- Current HSV vaccine efficiency is reviewed, highlighting limitations.
- Potential issues with live attenuated and inactivated HSV vaccine strategies are discussed.
- Comparative analysis with vaccines for cytomegalovirus, varicella-zoster virus, and Epstein-Barr virus is presented.
Conclusions:
- Development of effective HSV vaccines remains a significant challenge.
- Addressing both primary infection prevention and recurrent disease management is crucial for vaccine success.
- Lessons from other herpesvirus vaccines may inform future HSV vaccine design.